Doctor profile · Federal record

Dr. Shirisha Vallarapu, PAC

Physician Assistant · Fort Myers, FL

  • NPI 1730375460
  • Accepts Medicare
  • MIPS 77.3 / 100 · 2023
  • 22 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
13681 Metropolis Ave
Fort Myers, FL 339124318
(800) 400-3376
fax (239) 561-3020
Mailing address
151 Southhall Ln Ste 300
Maitland, FL 327517172

Credentials & registration

NPPES · NUCC
NPI registered
September 2007 — 19 yrs on file
Profile last updated
March 26, 2025
Year of graduation
2004 — 22 yrs since
Specialty taxonomy
363A00000X — NUCC code
State license (1)
Florida #PA9111573

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1730375460. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
3,913
Distinct HCPCS
10
Medicare allowed
$221,495
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 1,152 228 $6
99213 Established patient office or other outpatient visit, 20-29 minutes 706 459 $78
17000 Destruction of precancer skin growth, 1 growth 490 328 $46
96900 Application of ultraviolet light to skin 380 20 $21
17110 Destruction of skin growth, 1-14 growths 271 196 $91
11104 Punch biopsy, first skin growth 182 164 $108
99212 Established patient office or other outpatient visit, 10-19 minutes 136 119 $48
99214 Established patient office or other outpatient visit, 30-39 minutes 136 100 $110
99203 New patient office or other outpatient visit, 30-44 minutes 81 81 $97
11102 Biopsy of related skin growth, first growth 68 65 $75

In context: peer comparison

Among 96 peers in this city , average services per provider: 114. This provider delivers 34× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$4,054
Transactions
78
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Incyte Corporation 12 $2,350.47
Janssen Biotech, Inc. 14 $356.90
ABBVIE INC. 16 $269.47
GENZYME CORPORATION 6 $265.03
Dermavant Sciences, Inc. 10 $198.41
Regeneron Healthcare Solutions, Inc. 5 $117.44
PFIZER INC. 4 $92.01
UCB, Inc. 2 $73.92
REVANCE THERAPEUTICS, INC. 1 $67.46
E.R. Squibb & Sons, L.L.C. 2 $45.68
SUN PHARMACEUTICAL INDUSTRIES INC. 2 $39.68
MAYNE PHARMA COMMERCIAL LLC 1 $34.16
LEO Pharma Inc. 1 $29.35
Novartis Pharmaceuticals Corporation 1 $22.63
Fresenius Kabi USA, LLC 1 $22.54

By nature of payment

Food and Beverage
$2,027
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
$1,020
Travel and Lodging
$998
Education
$8

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
747
Patients
472
Total drug cost
$93,501
Drug Type Claims Patients Total cost
Ketoconazole Generic 144 71 $2,400
Triamcinolone Acetonide Generic 114 87 $1,510
Hydrocortisone Generic 110 89 $641
Clobetasol Propionate Generic 73 49 $4,877
Clindamycin Phosphate Generic 44 23 $1,054
Doxycycline Hyclate Generic 39 26 $1,225
Prednisone Generic 39 37 $91
Valacyclovir (Valacyclovir Hcl) Brand 32 26 $1,059
Mupirocin Generic 27 26 $282
Cephalexin Generic 26 25 $122

Frequently asked questions

Auto-generated from federal data
What is Dr. Shirisha Vallarapu's medical specialty?
Dr. Shirisha Vallarapu practices Physician Assistant in Fort Myers, FL.
Where does Dr. Shirisha Vallarapu practice?
Dr. Shirisha Vallarapu practices at 13681 Metropolis Ave, Fort Myers, FL 339124318. Office phone: 8004003376.
What is Dr. Shirisha Vallarapu's NPI?
Dr. Shirisha Vallarapu's National Provider Identifier (NPI) is 1730375460, issued by NPPES.
Does Dr. Shirisha Vallarapu accept Medicare assignment?
Yes. Dr. Shirisha Vallarapu accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Shirisha Vallarapu commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.